Tag Archives: Paul-Lim

“Tech is 47% of the index … [A]t an average P/E of 21.5, the Nasdaq is still considerably more expensive than the Dow Jones industrial average, the S&P 500, European stocks, emerging market stocks, and the list goes on and on. … “[T]he Nasdaq Biotech index now trades at P/E of around 50. Meanwhile, many […]